539 top medical experts on Monoclonal Gammopathy of Undetermined Significance across 33 countries and 30 U.S. states, including 471 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Monoclonal Gammopathy of Undetermined Significance: Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Hypergammaglobulinemia (970), Paraproteinemias (1,357) and Narrower Categories: Schnitzler Syndrome (452).
  4. Clinical Trials ClinicalTrials.gov : at least 48 including 5 Active, 12 Completed, 17 Recruiting
  5. Synonyms: Benign Monoclonal Gammopathies,  Monoclonal Gammapathy of Undetermined Significance,  Benign Monoclonal Gammopathies


  

        

                    


    Computing Expert Listing ...

);